These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7785793)

  • 1. Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients.
    Hama J; Nagata S; Takenaka T; Kino H; Kamoi K; Shimada S; Horiuchi M; Katori R
    Angiology; 1995 Jun; 46(6):511-6. PubMed ID: 7785793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of natriuretic peptide action by the beta-adrenergic blocker carvedilol in hypertensive rats: a new antihypertensive mechanism.
    Yoshimoto T; Naruse M; Tanabe A; Naruse K; Seki T; Imaki T; Muraki T; Matsuda Y; Demura H
    Endocrinology; 1998 Jan; 139(1):81-8. PubMed ID: 9421401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension.
    Nakaoka H; Kitahara Y; Amano M; Imataka K; Fujii J; Ishibashi M; Yamaji T
    Hypertension; 1987 Aug; 10(2):221-5. PubMed ID: 3038746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic effect of beta-adrenoceptor blockade on plasma levels of brain natriuretic peptide during exercise in essential hypertension.
    Tanaka M; Ishizaka Y; Ishiyama Y; Kato J; Kida O; Kitamura K; Kangawa K; Eto T
    Hypertens Res; 1996 Dec; 19(4):239-45. PubMed ID: 8986454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial-specific granule number and plasma atrial natriuretic peptide in rats: effects of beta-adrenoceptor blockade and sodium intake.
    Penner SB; Thliveris JA; McKenzie JK; Smyth DD
    Anat Rec; 1990 Dec; 228(4):418-24. PubMed ID: 1980994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating atrial natriuretic polypeptide in essential hypertension.
    Kohno M; Yasunari K; Matsuura T; Murakawa K; Takeda T
    Am Heart J; 1987 May; 113(5):1160-3. PubMed ID: 2953220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atrial natriuretic peptide, left ventricular mass and renin-angiotensin-aldosterone system in essential arterial hypertension of a mild or moderate degree].
    Gambini G; Talamonti D; Valori C
    G Ital Cardiol; 1992 Dec; 22(12):1397-403. PubMed ID: 1294423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide in human essential hypertension.
    Zachariah PK; Burnett JC; Ritter SG; Strong CG
    Mayo Clin Proc; 1987 Sep; 62(9):782-6. PubMed ID: 2957551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?].
    Stimpel M; Kaufmann W; Wambach G
    Z Kardiol; 1988; 77 Suppl 2():92-8. PubMed ID: 2970180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-adrenoceptor antagonist propranolol potentiates hypotensive action of natriuretic peptides.
    Yoshimoto T; Naruse M; Irie K; Tanabe A; Seki T; Tanaka M; Imaki T; Naruse K; Muraki T; Matsuda Y; Demura H
    Eur J Pharmacol; 1998 Jun; 351(1):61-6. PubMed ID: 9698206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the beta 1-blocker/beta 2-agonist celiprolol on atrial natriuretic peptide plasma levels in hypertensive patients.
    Papadopoulos CL; Kokkas B; Kotridis P; Karamouzis M; Haldoupi M; Platis A; Dadoush G; Kanonidis I
    Cardiovasc Drugs Ther; 1998 Sep; 12(4):345-6. PubMed ID: 9825178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a beta 1-receptor blocker on the plasma level of atrial natriuretic peptide in patients with essential hypertension in the exercise test].
    Plum J; Hollenbeck M; Heering P; Grabensee B
    Klin Wochenschr; 1990 May; 68(9):476-84. PubMed ID: 2162449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of atrial natriuretic peptide in patients with borderline and essential hypertension.
    Nakamura T; Ichikawa S; Sakamaki T; Fujie M; Yagi A; Kurashina T; Murata K
    Tohoku J Exp Med; 1988 Feb; 154(2):205-13. PubMed ID: 2968004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension.
    Colantonio D; Casale R; Desiati P; Giandomenico G; Bucci V; Pasqualetti P
    J Clin Pharmacol; 1991 Mar; 31(3):238-42. PubMed ID: 1826912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between the antihypertensive effects of bisoprolol and levels of plasma atrial natriuretic peptide in hypertensive patients.
    Baláti B; Phung H; Pousset F; Isnard R; Boisvieux A; Carayon A; Komajda M; Lechat P
    Fundam Clin Pharmacol; 2002 Oct; 16(5):361-8. PubMed ID: 12602461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of betaxolol on atrial natriuretic peptide regulation in patients with essential hypertension].
    Heering P; Hollenbeck M; Plum J; Grabensee B
    Z Kardiol; 1990 Feb; 79(2):134-8. PubMed ID: 2138833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of nifedipine on plasma atrial natriuretic peptide in normal subjects and hypertensive patients.
    Shigematsu S; Yamada T; Aizawa T; Takasu N; Shimizu Z
    Angiology; 1992 Jan; 43(1):40-6. PubMed ID: 1532485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of atenolol and zofenopril on plasma atrial natriuretic peptide are due to their interactions with target organ damage of essential hypertensive patients.
    Elijovich F; Laffer CL; Schiffrin EL
    J Hum Hypertens; 1997 May; 11(5):313-9. PubMed ID: 9205939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological functions of adrenomedullin and natriuretic peptides in patients with primary aldosteronism.
    Hu W; Zhou PH; Zhang XB; Xu CG; Wang W
    Endocrine; 2015 Mar; 48(2):661-8. PubMed ID: 25027294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.